bmoney18

/bmoney18

About bmoney18

This author has not yet filled in any details.
So far bmoney18 has created 841 blog entries.

Morning briefing: market news, upgrades/downgrades 2.17

Market news: US stock market will close on Monday, 2/20/17 for Presidents' Day http://www.precisiontrade365.com/fda-calendar-2/ Global market pullbacks ABBV increases buyback by $5B Ryan struggles to sell tax reform to fellow Republicans  http://www.politico.com/story/2017/02/paul-ryan-tax-reform-republicans-235117 CELG announces positive from phase 3 SUNBEAM http://finance.yahoo.com/news/celgene-announces-positive-results-phase-123000513.html US future: -75 points, S&P 50 -0.36% Global index: DAX -0.39%, Stoxx 50 -0.67%, Nikkei [...]

By | February 17th, 2017|Morning Upgrades & Downgrades, Public Access|0 Comments

Tesla, Inc (TSLA) our short note yesterday for members. 2.16

TSLA stock intra day -3.35%. See our team note short of before and after chart Noted of short under $280 and target $275 and $270, so far today's lows at $269.50  intra-day 2/15 note as we took short via puts intra day 2/16 stock is down -3.25% as writing this blog. Target achieved.

By | February 16th, 2017|Educational Chart Set ups, Public Access|0 Comments

Morning briefing: Market news, upgrades/downgrades 2.16

Market news: Building permts 1.285M vs 1.23M Consensus Initla Jobless claims 239k vs 245k est Housing starts -2.6% vs 0.1% consensus SNAP Snap Seeks to Raise as Much as $3.2 Billion in U.S. IPO  https://www.bloomberg.com/news/articles/2017-02-16/snap-seeks-to-raise-as-much-as-3-2-billion-in-initial-offering IONS and Akcea close on strategic collbaration... PR http://finance.yahoo.com/news/ionis-akcea-close-strategic-collaboration-120000994.html and IONS to receive $75m from NVS VRX FDA approves new [...]

By | February 16th, 2017|Morning Upgrades & Downgrades, Public Access|0 Comments

ACAD, RDUS, TSRO Three biotech with latest speculation buyout rumors. 2.15

I've been a trader and investor for the biotechnology sector for many years, the unconfirmed "speculation buyout rumors" spreading around wall street are a norm these days. Basically, everyone thinks their stock is a buyout candidate, but these buyout rumors tend to be false and once in a while it's true. The rumors [...]

By | February 15th, 2017|Educational Chart Set ups, Public Access|0 Comments

CTRP, FSLR , CELG three breakout charts and note share to members ahead 2.15

These are chart and notes share to members ahead of the breakout this week. All generate profits.  Feb 10, part of Sunday trade plan  Feb 10, Sunday trade plan  Tuesday 2/14 trade plan

By | February 15th, 2017|Educational Chart Set ups, Public Access|0 Comments

Morning briefing: Market news: upgrades/downgrades 2.15

Market news: Fed chair Janet Yellen testify on the U.S economy at 10am ET WMT AMZN Warren Buffett just dropped Walmart and signaled the death of retail as we know it  http://www.msn.com/en-us/money/companies/warren-buffett-just-dropped-walmart-and-signaled-the-death-of-retail-as-we-know-it/ar-AAmWKmg?li=BBmkt5R&ocid=spartanntp NBIX files automatic mixed securities shelf AAPL, LUV AAL, DAL UAL Berkshire takes huge bite of Apple, boosts airline stakes via Reuters http://www.reuters.com/article/us-investment-funds-buffett-idUSKBN15T2VJ [...]

By | February 15th, 2017|Morning Upgrades & Downgrades, Public Access|0 Comments

Morning briefing: market news, upgrades/downgrades 2.14

Market news: Fed chair Yellen to testifies at 10am ET GILD Presents New Phase 2 Data on Bictegravir, an Investigational Integrase Strand Transfer Inhibitor for the Treatment of HIV http://finance.yahoo.com/news/gilead-presents-phase-2-data-234500652.html AET HUM terminate $34 billion deal via Reuters http://www.reuters.com/article/us-humana-m-a-aetna-idUSKBN15T1HN CYNO HOLX Hologic to acquire Cynosure for $66.00 per share in cash AVIR Antiviral Vependavir fails Phase 2b [...]

By | February 14th, 2017|Morning Upgrades & Downgrades, Public Access|0 Comments

Morning briefing: Market news, upgrades/downgrades 2.13

Market news: AGN ZLTQ Allergan to acquire ZELTIQ for $56.50 per share, or $2.47B XOMA prices $25m direct registered direct offering SAGE Advances SAGE-217 into Placebo-Controlled Phase 2 Clinical Trial in Major Depressive Disorder http://finance.yahoo.com/news/sage-therapeutics-advances-sage-217-120000424.html PCLN Evercore ISI expect solid Q4,  conservative guidance. Earning reports on 2/27 US indices future: Dow +59.5 points, S&P 500 +0.24% [...]

By | February 13th, 2017|Morning Upgrades & Downgrades, Public Access|0 Comments

Morning briefing: Market news, upgrades/downgrades 2.10

Market news: ICPT Provide Update on Phase 3 REGENERATE Trial of Obeticholic Acid for the Treatment of NASH Patients with Liver Fibrosis http://ir.interceptpharma.com/releasedetail.cfm?ReleaseID=1011392 SKX +11.25% pre market, yesterday earning reports Q4 revenue $764.3M, consensus $723.72M US future: Dow +33 points, S&P 500 +0.12% Dax +0.13%, Stoxx 50 -0.40%, Nikkei +2.33%, Hang Seng +0.45% Commodities: [...]

By | February 10th, 2017|Morning Upgrades & Downgrades, Public Access|0 Comments

Morning briefing: market news, upgrades/downgrades 2.9

Market news: TWTR earning reports: Q4 EPS 16c vs 12c est, rev $717m vs $ $740.14m est. No guidance for Q1 TSLA Tesla pausing factory for model 3 preparation this month via Reuters  http://www.reuters.com/article/us-tesla-model-idUSKBN15N2W7?feedType=RSS&feedName=topNews&utm_source=twitter&utm_medium=Social CVS earning reports: Q4 adjusted EPS $1.71 vs $1.67 est KO earning reports: Q4 adjusted EPS 37c vs 37c [...]

By | February 9th, 2017|Morning Upgrades & Downgrades, Public Access|0 Comments